Bradykinin-Induced Functional Competence and Trafficking of the δ-Opioid Receptor in Trigeminal Nociceptors
Open Access
- 28 September 2005
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 25 (39) , 8825-8832
- https://doi.org/10.1523/jneurosci.0160-05.2005
Abstract
Peripheral opioid analgesia is increased substantially after inflammation. We evaluated the hypothesis that an inflammatory mediator, bradykinin (BK), evokes functional competence of the δ-opioid receptor (DOR) for inhibiting trigeminal ganglia (TG) sensory neurons. We also evaluated whether BK evokes trafficking of the DOR to the plasma membrane. Rat TG cultures were pretreated with BK (10 μm) or vehicle, and the effects of DOR agonists ([d-Pen2,5]-enkephalin or [d-Ala2,d-Leu5]-enkephalin) on BK (10μm)/prostagladin E2 (PGE2; 1 μm)-stimulated immunoreactive calcitonin gene-related peptide (iCGRP) release or PGE2 (1 μm)-stimulated cAMP accumulation were measured. The effect of BK treatment on opioid receptor trafficking was evaluated by DOR immunohistochemistry, cell-surface DOR biotinylation, and live imaging of neurons transfected with mDOR–green fluorescent protein. BK pretreatment rapidly and significantly increased DOR agonist inhibition of evoked iCGRP release and cAMP accumulation. These effects of BK pretreatment were blocked by a B2receptor antagonist (HOE-140; 10μm) or a protein kinase C (PKC) inhibitor [bisindolymaleimide (BIS); 1μm]. Moreover, BK treatment rapidly and significantly increased the accumulation of DOR in the plasma membrane. However, BK-induced trafficking of DOR was not reversed by pretreatment with BIS, nor was trafficking evoked by application of a PKC activator PMA (200 nm). These data suggest that BK, in a PKC-dependent manner, induces rapid functional competence of DOR for inhibiting TG nociceptors and in a PKC-independent manner rapidly induces trafficking of DOR to the plasma membrane. These findings indicate that exposure to certain inflammatory mediators rapidly alters the signaling properties and neuronal localization of DOR, possibly contributing to peripheral opioid analgesia.Keywords
This publication has 43 references indexed in Scilit:
- Secrets of the opium poppy revealedNeuropharmacology, 2004
- Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2Nature, 2003
- Functional Interactions between μ Opioid and α2A-Adrenergic ReceptorsMolecular Pharmacology, 2003
- Bradykinin B2 Receptor Activates Extracellular Signal-Regulated Protein Kinase in mIMCD-3 Cells via Epidermal Growth Factor Receptor TransactivationThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Up-regulation and trafficking of δ opioid receptor in a model of chronic inflammation: implications for pain controlPain, 2003
- Temporal Regulation of Agonist Efficacy at 5-Hydroxytryptamine (5-HT)1A and 5-HT1BReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Detection of Bradykinin and Bradykinin-β2 Receptors in the Porcine Endometrium During the Estrous Cycle and Early Pregnancy1Biology of Reproduction, 2002
- Heterologous Activation of Protein Kinase C Stimulates Phosphorylation of δ-Opioid Receptor at Serine 344, Resulting in β-Arrestin- and Clathrin-mediated Receptor InternalizationPublished by Elsevier ,2001
- Endogenous δ‐Opioid and ORL1 Receptors Couple to Phosphorylation and Activation of p38 MAPK in NG108‐15 Cells and This Is Regulated by Protein Kinase A and Protein Kinase CJournal of Neurochemistry, 1999
- Activation of μ opioid receptors inhibits transient high- and low-threshold Ca 2+ currents, but spares a sustained currentNeuron, 1991